High‐throughput CRISPR screen of GWAS risk loci in human microglia reveals novel risk genes for Alzheimer's disease and multiple sclerosis
The combination of iPSC-based cell models and functional genomics allowed for systematic perturbation of AD and MS risk SNPs, revealing previously uncharacterized risk genes linking neuroimmune pathways to disease pathophysiology. Ongoing studies are exploring the role of altered expression levels of MAF, ELMO1 and other screen hits in microglial phenotypes, including effects on neurons and astrocytes in co-culture and organoid systems.
Authors
- Keya Viswanathan
- Olivia Corradin (ORCID: https://orcid.org/0000-0002-9484-0873)
- Xochitl Luna
- Rudolf Jaenisch
- Michael D. Gallagher
- Yiran Cheng (ORCID: https://orcid.org/0000-0001-5589-2024)
- Katheryn EA Hazel
- Bingbing Yuan (ORCID: https://orcid.org/0000-0002-8460-5124)
- Heather Keys
- Richard A. Young
- George W Bell
- Zeynep Aydin
- Moritz List
- Wenjuan Du
Institutions
- Whitehead Institute for Biomedical Research (US)
- Massachusetts Institute of Technology (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_105086
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00